NCT04205630 2024-05-30
SYD985 in Patients With HER2-expressing Recurrent, Advanced or Metastatic Endometrial Carcinoma
Byondis B.V.
Phase 2 Completed
Clinical Trials
4 trialsNCT04235101 2024-01-05
Phase I Study of SYD985 With Niraparib in Patients With Solid Tumors
Byondis B.V.
Phase 1 Completed
NCT04983238 2024-01-05
Evaluation of Safety and Efficacy of Sodium Thiosulfate (BYON5667) Eye Drops to Reduce Ocular Toxicity in Cancer Patients Treated With SYD985
Byondis B.V.
Phase 1/2 Completed
NCT02277717 2023-08-14
First-in-human Study With the Antibody-drug Conjugate SYD985 to Evaluate Safety and Efficacy in Cancer Patients
Byondis B.V.
Phase 1 Completed